A Case of Bilateral Vestibular Hypofunction Following Oseltamivir Medication
- Author:
Ho Yeop KIM
1
;
Seong Ki AHN
;
Dong Gu HUR
Author Information
1. Department of Otolaryngology, Gyeongsang National University School of Medicine, Jinju, Korea. skahn@gnu.ac.kr
- Publication Type:Case Report
- Keywords:
Vestibular function test;
Oseltamivir;
Drug toxicity
- MeSH:
Abdominal Pain;
Containment of Biohazards;
Diarrhea;
Drug Toxicity;
Female;
Humans;
Influenza, Human;
Nausea;
Oseltamivir;
Pandemics;
Vestibular Function Tests;
Viruses;
Vomiting;
World Health Organization
- From:Journal of the Korean Balance Society
2013;12(1):27-30
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The threat of pandemic influenza has focused attention and resources on virus surveillance, prevention, and containment. The World Health Organization has strongly recommended the use of the antiviral drug, Oseltamivir (Tamiflu(R)), to treat and prevent pandemic influenza infection. In recent years, there have been case reports of vestibulocochlear events during or after oseltamivir treatment, other countries. Oseltamivir is generally well-tolerated and its most frequent adverse effects include nausea and vomiting, diarrhea, and abdominal pain. Up to now, bilateral vestibular hypofunction after oseltamivir medication has not been reported. Herein, we report a very rare case of a 36-year-old female with bilateral vestibular hypofunction following oseltamivir medication.
